The Substance Abuse and Mental Health Services Administration yesterday issued guidance for health care and addiction professionals using methadone, naltrexone or buprenorphine to treat patients with opioid use disorder. Mandated by the Comprehensive Addiction and Recovery Act, the guidance offers appropriate prescribing practices and strategies for supporting patients. It also educates patients, families and the general public about the medications. “We know that people can and do recover from opioid use disorders when they receive appropriate treatment, and medication-assisted treatment’s success in treating opioid use disorders is well documented,” said Elinore McCance-Katz, M.D., assistant secretary for mental health and substance use at the Department of Health and Human Services. For an AHA toolkit and other resources to help hospitals and health systems tackle the opioid crisis, visit www.aha.org/opioidtoolkit.

Related News Articles

Headline
The Food and Drug Administration yesterday approved a mobile medical application to help increase retention in outpatient treatment programs for opioid use…
Headline
U.S. life expectancy at birth continued to decline in 2017, from 78.7 years to 78.6, largely due to increase deaths from unintentional injuries, according to a…
Insights and Analysis
Parkview Health is working to develop a mobile app that would serve as an intervention for Indianans struggling with opioid-related substance use disorders.…
Insights and Analysis
Also in this weekly roundup of health care news: the county that’s leading the nation in reversing opioid overdose deaths, and meth-related overdoses are on…
Weekly Reading
Also in this weekly roundup of health care news: the county that’s leading the nation in reversing opioid overdose deaths, and meth-related overdoses are on…
Headline
Health care providers and others can apply through Jan.